Occudo Quantitative Strategies’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-98,452
| Closed | -$561K | – | 1091 |
|
2023
Q1 | $561K | Sell |
98,452
-67,061
| -41% | -$382K | 0.05% | 481 |
|
2022
Q4 | $1.67M | Buy |
165,513
+127,062
| +330% | +$1.28M | 0.19% | 156 |
|
2022
Q3 | $862K | Sell |
38,451
-54,536
| -59% | -$1.22M | 0.07% | 463 |
|
2022
Q2 | $2.3M | Buy |
+92,987
| New | +$2.3M | 0.19% | 144 |
|
2021
Q2 | – | Sell |
-3,034
| Closed | -$250K | – | 938 |
|
2021
Q1 | $250K | Sell |
3,034
-2,731
| -47% | -$225K | 0.05% | 553 |
|
2020
Q4 | $524K | Buy |
+5,765
| New | +$524K | 0.16% | 227 |
|